What Researchers Did
Researchers investigated if hyperbaric oxygen (HBO) could improve the delivery of engineered bacteria (EcN-cypate) into tumors for synergistic photothermal immunotherapy.
What They Found
They found that hyperbaric oxygen (HBO) effectively depleted the dense extracellular matrix, enhancing bacterial accumulation within tumors. HBO treatment significantly increased the intratumoral accumulation of engineered bacteria and facilitated immune cell infiltration, leading to successful tumor eradication via photothermal therapy and immunotherapy.
What This Means for Canadian Patients
This research suggests a potential noninvasive strategy to improve the delivery and effectiveness of bacteria-mediated cancer therapies. If translated clinically, this approach could offer Canadian patients a new, synergistic treatment option for various cancers, potentially improving outcomes.
Canadian Relevance
This study was not conducted in Canada and does not have a direct Canadian connection.
Study Limitations
A limitation is that this study was conducted in a preclinical setting, and further research is needed to confirm these findings in human clinical trials.